India's pharmaceutical sector is experiencing rapid growth, with a 7.8% year-on-year increase in April 2025, driven by strong ...

India’s pharmaceutical sector grew 7.8% in April 2025, driven by exports, innovation, and government schemes, reinforcing its ...

India has transformed itself into a global health leader in terms of affordability, innovation, and inclusivity over the past ...

Trump said he would introduce a “most favoured nation” (MFN) policy whereby the US pays “the same price as the nation that ...

Nifty Pharma stocks, including GSK, Jubilant Pharmova, Eris Life, Gland Pharma and Torrent Pharma, saw gains up to 8% as ...

Indian market for these drugs has grown to nearly Rs 600 crore and is expected to keep growing. Weight-loss drugs are ...

Indian drug cos are increasing their presence in the insulin market. They are competing with multinational corporations.

By linking US drug prices to those paid in similar economies, order could alter how pharmaceutical companies price their ...

The proposed 10% tariff, which mirrors India’s tax on US drug imports, could severely impact profit margins for generic drug ...

The order is expected to impact innovator companies, which may spend less on research in an effort to cut costs, analysts ...

Indian pharmaceutical shares dropped up to 7% following US President Donald Trump's pledge to significantly lower US drug ...

Qure.AI, an India-based startup providing artificial intelligence tools to healthcare firms, is aiming to turn profitable in ...